
With 36-hour Cialis and Cialis for daily use, men have the flexibility they are looking for," said Cialis should not be taken by anyone who is allergic to Cialis or Adcirca® (tadalafil), or any of its ingredients.
| Formulation | Dosage Range | Appearance | Typical Use | Packaging Options |
|---|---|---|---|---|
| Tablet | 2.5 mg, 5 mg, 10 mg, 20 mg | Blue, oval | ED, BPH | Blister packs |
| Orally Dispersible | 10 mg | Peach-colored | ED | Blister packs |
| Special Formulations | Daily use tablet | White, round | Regular use | Blister, bottle |
Anyone who experiences any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or difficulty breathing or swallowing, should call a healthcare provider or get help right away.
Lilly has many reasons to applaud Cialis on its 10th anniversary, and is looking forward to even more success with Cialis for years to come.
About Cialis Cialis is indicated for the treatment of men with erectile dysfunction (ED), men with the signs and symptoms of benign prostatic hyperplasia (BPH), and men with both ED and the signs and symptoms of BPH. If Cialis is used with finasteride to initiate BPH treatment, such use is recommended for up to 26 weeks. Cialis is not for women or children. It is important to note that Cialis is not to be taken with medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate which are often prescribed for chest pain; or with recreational drugs called "poppers" like amyl or butyl nitrite, as the combination may cause an unsafe drop in blood pressure; or if allergic to Cialis or Adcirca® (tadalafil), or any of its ingredients.
"An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals". Archived from the original on 17 October 2014. Archived from the original on 29 April 2015. ^ "FDA approves tadalafil for pulmonary arterial hypertension". Archived from the original on 13 November 2014.
"The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. Archived from the original on 16 December 2017. "Drugs giant says its new pill will pack more punch than rival Viagra". Archived from the original on 3 April 2007. ^ "FDA approves Cialis to treat benign prostatic hyperplasia".
Archived from the original on 18 January 2017. ^ a b Elliott S (10 January 2006). Archived from the original on 22 April 2018. "Viagra and the Battle of the Awkward Ads". "First they tried to play it safe; Ads for erectile dysfunction drug Cialis bared all - including a scary potential side effect. Important Safety Information for Cialis® (tadalafil) tablets What Is The Most Important Information I Should Know About Cialis?
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 20mg | 120 + 8 Pills | 188.15€ 179.19€ | |
| Cialis Generic | 40mg | 60 + 6 Pills | 130.98€ 124.74€ | |
| Cialis Super Active | 20mg | 30 + 6 Pills | 128.09€ 121.99€ | |
| Cialis Generic | 2.5mg | 60 + 4 Pills | 83.43€ 79.46€ | |
| Cialis Black | 80mg | 90 + 6 Pills | 207.88€ 197.98€ | |
| Cialis Generic | 20mg | 270 + 10 Pills | 335.21€ 319.25€ | |
| Cialis Generic | 5mg | 20 Pills | 41.99€ 39.99€ | |
| Cialis Professional | 40mg | 10 Pills | 65.09€ 61.99€ | |
| Cialis Black | 80mg | 10 Pills | 43.27€ 41.21€ | |
| Cialis Original | 20mg | 92 + 4 Pills | 377.99€ 359.99€ |
take medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate which are often prescribed for chest pain as the combination may cause an unsafe drop in blood pressure use recreational drugs called "poppers" like amyl nitrite and butyl nitrite are allergic to Cialis or Adcirca® (tadalafil), or any of its ingredients. Call your healthcare provider or get help right away if you experience any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or difficulty breathing or swallowing After taking a single tablet, some of the active ingredient of Cialis remains in your body for more than 2 days. The active ingredient can remain longer if you have problems with your kidneys or liver, or you are taking certain other medications.
U.S. Cialis sales for 2012 were$782 million, an 11 percent increase.3 Over 2.5 million prescriptions have been filled through the Promise Program, with approximately 1.5 million for Cialis for once daily use. The Cialis Promise Program provides men with ED an opportunity to try Cialis for free, as prescribed by their doctor. Cialis is covered on many major health plans, and more than 114 million lives have commercial formulary access to Cialis for once daily use with a correct quantity limit of 30 tablets per 30 days. "Men with ED tell us that they value a treatment option that allows them to respond when the moment is right. Stop sexual activity and get medical help right away if you get symptoms such as chest pain, dizziness, or nausea during sex.
It was risky but it has paid off". Archived from the original on 14 December 2019. "Two Pills Look to Topple Viagra's Reign in Market; Levitra Expects Approval Next Month, Cialis Later This Year". Archived from the original on 24 January 2021. Archived from the original on 10 September 2015.
Archived from the original (PDF) on 29 August 2021. Archived from the original on 9 November 2021. "Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's disease: a retrospective comparative analysis". "PD21-09 Daily Tadalafil Therapy: A New Treatment Option for Peyronie's Disease?". Grünenthal announces that it agreed to acquire the commercial rights to Cialis® from Eli Lilly and Company in Mexico, Brazil and Colombia, further strengthening Grünenthal's footprint in Latin America.
As part of the acquisition, Grünenthal will transfer the manufacturing of Cialis® to its production site in Chile. Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly strengthening its profitability. Aachen, Germany, 2 June 2025 – Grünenthal today announced the acquisition of the commercial rights to Cialis® (tadalafil) in Mexico, Brazil and Colombia from Eli Lilly and Company. Over the next few years, Grünenthal and Lilly will work together to transfer the manufacturing to Grünenthal's production site in Santiago, Chile, that will supply Cialis® for Mexico, Brazil and Colombia moving forward. The transaction is expected to close in the third quarter of 2025, subject to the satisfaction of customary closing conditions. Sexual activity can put an extra strain on your heart, especially if your heart is already weak from a heart attack or heart disease.
What Should I Tell My Healthcare Provider Before Taking Cialis?
Grünenthal will finance the generic cialis softtabs transaction using available liquidity. The financial terms of the transaction are not disclosed. Cialis® is indicated for the oral treatment of erectile dysfunction and signs and symptoms of benign prostatic hyperplasia in adult men1. The acquisition will expand Grünenthal's Latin American Men's Health product portfolio. "Executing on our strategy of targeted acquisitions, Cialis® will expand our existing portfolio in the region and strengthen Grünenthal's Latin American business", says Gabriel Baertschi, CEO, Grünenthal.
"In 2022, we acquired Nebido®, a long-acting treatment for testosterone deficiency, and with Cialis® we can continue to serve our existing customer base and foster our growth in key Latin American markets." Through the acquisition of Cialis®, Grünenthal continues executing its strategy of acquiring established medicines to expand its portfolio and increase its profitability. Since 2017, Grünenthal has invested over €2 billion in the acquisition of established medicines, including Nebido®, the European rights to Crestor® and Nexium®, as well as the global rights to Vimovo® (excluding the U.S. and Japan), Qutenza® and Zomig® (excluding Japan). In 2023, Grünenthal established Grünenthal Meds, a joint venture with Kyowa Kirin International, which manages a portfolio of 13 brands primarily focused on pain management and, in 2024, acquired the US company Valinor Pharma and the product Movantik®. 1 In Mexico Cialis® is indicated for the oral treatment of erectile dysfunction and symptoms of benign prostatic hyperplasia in adult men.
About Grünenthal Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain. Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America, and the U.S. Only your healthcare provider and you can decide if Cialis is right for you.
Our products are available in approx. In 2024, Grünenthal employed around 4,300 people and achieved revenues of €1.8 billion. Follow us on: LinkedIn: Grunenthal Group Instagram: grunenthal Click here for our Grünenthal Report 2024/2025 Grünenthal announces acquisition of the rights to Cialis® from Lilly in Mexico, Brazil & Colombia (pdf, 137.3 KB) Conversations that used to be taboo for men are now taking place in bedrooms and exam rooms. Men with conditions like erectile dysfunction (ED) are talking more openly with their partners and their physicians.1 Part of this evolution was the U.S. approval of Cialis for use as needed (5 mg, 10 mg, and 20 mg) on "Witnessing the evolution of Cialis since it entered the market 10 years ago, and the positive effects it continues to have on the treatment of erectile dysfunction, has been exciting," said Dr.
It is important to note that Cialis is not to be taken with medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate, which are often prescribed for chest pain; or with recreational drugs called "poppers" like amyl or butyl nitrite, as the combination may cause an unsafe drop in blood pressure. Though Cialis was not the first to market in many countries, it has delivered global success and shown the importance of offering men a choice in their ED treatment. TIME Magazineincluded Cialis on its list of Best Inventions of 2003. Cialis obtained "blockbuster status" in 2005, when it reached $1 billion USDin worldwide sales. In 2008, Cialis was approved in the U.S.
for buy cialis powder once-daily use, giving men two different dosing options to treat ED. In 2011, Cialis was the first and only medication approved to treat both ED and the signs and symptoms of benign prostatic hyperplasia (ED+BPH). To date, Cialis has treated an estimated 41 million patients around the globe. Cialis is the most prescribed oral ED treatment by Urologists. For the full year of 2012, worldwide Cialis sales increased 3 percent to $1.9 billion. Ask your healthcare provider if your heart is healthy enough for you to have sexual activity.
| Development Area | Innovation Focus | Expected Benefits | Timeline |
|---|---|---|---|
| New Formulations | Long-acting or dissolvable tablets | Increased patient convenience | 2025-2027 |
| Combination Drugs | Cialis + other ED meds | Improved efficacy and options | 2024-2026 |
| Digital Health Integration | Apps for dosage reminders | Better adherence, monitoring | 2024 onward |
| Personalized Medicine | Tailored dosing based on genetics | Enhanced safety and effectiveness | 2025-2028 |